Shandong Buchang Pharmaceuticals Co., Ltd.
Industry Group: Pharmaceuticals
Country/Region: China
Identifier: SHG:603858
Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 876 out of 919
Universe
Global Universe 14740 out of 16078
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Camurus AB |
23.3
Medium
|
157 out of 919 |
Jilin Aodong Pharmaceutical Group Co., Ltd. |
33.2
High
|
672 out of 919 |
Lotus Pharmaceutical Co., Ltd. |
36.8
High
|
829 out of 919 |
Shandong Buchang Pharmaceuticals Co., Ltd. |
39.2
High
|
876 out of 919 |
Indivior PLC |
39.5
High
|
880 out of 919 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Shandong Buchang Pharmaceuticals Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Shandong Buchang Pharmaceuticals Co., Ltd.'s Management of ESG Material Risk is Weak
How do the ESG Risk Ratings work?
Top Material ESG Issues for Shandong Buchang Pharmaceuticals Co., Ltd.
Understand how exposed companies are to specific material ESG issues and how well companies are managing these issues.
What are Material ESG Issues?
Material ESG issues are issues that are considered to be financially material to a given company in a relevant sub-industry.
Controversy Rating
Highest Controversy level that has impacted Shandong Buchang Pharmaceuticals Co., Ltd.'s ESG Risk Rating in the last three years
Highest Controversy Level